Bruix, J, Qin, S, Merle, P, Granito, A, Huang, Y-H, Bodoky, G, Pracht, M, Yokosuka, O, Rosmorduc, O, Breder, V, Gerolami, R, Masi, G, Ross, P J, Song, T, Bronowicki, J-P, Ollivier-Hourmand, I, Kudo, M, Cheng, A-L, Llovet, J M, Finn, R S, LeBerre, M-A, Baumhauer, A, Meinhardt, G & Han, G 2016, ' Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial ', Lancet . https://doi.org/10.1016/S0140-6736(16)32453-9